Biden’s move on vaccine patents represents blow for the second-biggest spender on Washington lobbying
May 06, 2021 at 13:17 PM EDT
The Biden administration’s Wednesday decision to support waiving intellectual-property protections for COVID-19 vaccines counts as a significant disappointment for drugmakers, who rank among the biggest spenders on Washington lobbying.
